A DIVERSIFIED GROWTH INVESTMENT
Abbott is a large-cap diversified healthcare company driving performance across a broad portfolio of leading businesses aligned with favorable long-term healthcare and emerging market trends to generate top-tier growth, expanding margins and strong cash flow.
Our sales are diversified throughout the world, with 30 percent of sales in the United States, 30 percent of sales in other developed markets (Canada, Western Europe, Japan, Australia) and 40 percent in emerging markets—particularly in India, China, Russia and Brazil.
Abbott provides a range of financial news and investor resources, including annual reports, shareholder FAQs, financial releases, analyst coverage and corporate political participation. Please contact us to receive printed materials or register to keep up to date through e-mail alerts.
The principal market for Abbott’s common shares is the New York Stock Exchange while shares are also listed on the Chicago Stock Exchange and traded on various regional and electronic exchanges. To learn more, access all of Abbott’s SEC filings.
ABBOTT AND ABBVIE
In January 2013, Abbott separated into two independent companies: Abbott and AbbVie. To learn more about AbbVie, visit AbbVie.com.
For shareholders requesting information on cost/tax basis information for Abbott and AbbVie shares, please go to the AbbVie Separation page.
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.